Cargando…
Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia
Immune thrombocytopenia (ITP) is a bleeding disorder caused by dysregulated B- and T- cell functions, which lead to platelet destruction. A well-recognized mechanism of ITP pathogenesis involves anti-platelet and anti-megakaryocyte antibodies recognizing membrane glycoprotein (GP) complexes, mainly...
Autores principales: | Zheng, Shiying Silvia, Ahmadi, Zohra, Leung, Halina Hoi Laam, Wong, Rose, Yan, Feng, Perdomo, José Sail, Chong, Beng Hock |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425302/ https://www.ncbi.nlm.nih.gov/pubmed/35199503 http://dx.doi.org/10.3324/haematol.2021.279751 |
Ejemplares similares
-
Adolescents and young adults with newly diagnosed primary immune thrombocytopenia
por: Schifferli, Alexandra, et al.
Publicado: (2023) -
Circulating primers enhance platelet function and induce resistance to antiplatelet therapy
por: Blair, T A, et al.
Publicado: (2015) -
Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets
por: van Osch, Thijs L.J., et al.
Publicado: (2022) -
Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia
por: Wang, Long, et al.
Publicado: (2022) -
Platelet dysfunction in platelet-type von Willebrand disease due to the constitutive triggering of the Lyn-PECAM1 inhibitory pathway
por: Bury, Loredana, et al.
Publicado: (2021)